KRAS and lung cancer: In this study we demonstrated that caspase-4 was highly present in the tumor mass compared to non-cancerous tissues of NSCLC patients and was responsible for cell proliferation, suggesting it as a novel oncoprotein that collaborates with c-MyC and K-Ras to promote lung cancer, affecting patients’ survival rate.